HANNAH HORTON: Open Payments
NPI 1669184610 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $59 |
| Antares Pharma, Inc. | 2 | $55 |
| Lundbeck LLC | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Ardelyx, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| TOLMAR, INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
Products named: XYOSTED, CAPLYTA, REXULTI, EVENITY, IBSRELA, Auvelity, JATENZO, MOUNJARO.
Industry payments across LA — which companies pay providers there.
